RCKT
Rocket Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +26.1% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 55.09M | $188.40M | +4 | −5 |
| Q1 2026 | 83 | +2 | 57.14M | $204.44M | +8 | −6 |
| Q4 2025 | 81 | +2 | 51.01M | $179.05M | +2 | — |
| Q3 2025 | 15 | 0 | 38.20M | $124.54M | — | — |
| Q2 2025 | 12 | -1 | 25.35M | $62.12M | +2 | −3 |
| Q1 2025 | 10 | -1 | 24.61M | $164.16M | +1 | −2 |
| Q4 2024 | 11 | 0 | 29.17M | $366.63M | +1 | −1 |
| Q3 2024 | 10 | 0 | 19.68M | $363.43M | +2 | −2 |
| Q2 2024 | 10 | — | 17.23M | $370.95M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 14.00M | +24.5% | $175.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 14.00M | +24.5% | $175.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 14.00M | +24.5% | $175.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 14.00M | +24.5% | $175.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 14.00M | +24.5% | $175.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 14.00M | +24.5% | $175.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 4.12M | +91.9% | $51.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 4.12M | +91.9% | $51.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | State Street Global Advisors ✦ (passief) | 3.46M | — | $43.47M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 3.15M | -1.9% | $39.58M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 3.15M | -1.9% | $39.58M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 1.75M | +8.3% | $22.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 1.75M | +8.3% | $22.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 1.57M | +3163.9% | $19.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Marshall Wace ✦ | 456.76K | +4422.4% | $5.74M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 456.76K | +4422.4% | $5.74M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 336.91K | -72.0% | $4.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 218.52K | Nieuw | $2.75M | 0.0% | New | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 65.86K | +248.3% | $827,911 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 65.86K | +248.3% | $827,911 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 41.14K | +88.6% | $517,155 | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $2.75M | 0.0% |
Verlaten
| Norges Bank | $2.94M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 195 houders, 96.37M aandelen, $341.40M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 2.29K aand · $7,753
Officer · 631 aand · $2,133
Officer · 4.70K aand · $16,449
Officer · 36.66K aand · $128,266
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie